Provided by Tiger Trade Technology Pte. Ltd.

Pieris Pharmaceuticals

13.60
0.0000
Volume:- -
Turnover:743.03K
Market Cap:17.96M
PE:-1.09
High:13.60
Open:13.60
Low:13.60
Close:13.60
52wk High:22.32
52wk Low:6.20
Shares:1.32M
Float Shares:776.02K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.5338
EPS(LYR):-21.8005
ROE:-68.21%
ROA:-28.31%
PB:1.10
PE(LYR):-0.62

Loading ...

Dec 17, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Correspondence

Form CORRESP - Correspondence
Nov 07, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 05, 2024

Correspondence

Form CORRESP - Correspondence
Oct 29, 2024

Correspondence

Form CORRESP - Correspondence
Oct 17, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 15, 2024

Correspondence

Form CORRESP - Correspondence
Oct 15, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 03, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 23, 2024

Correspondence

Form CORRESP - Correspondence
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report